Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Venture Life ( (GB:VLG) ) has provided an announcement.
Venture Life Group has repurchased 85,000 ordinary shares at a volume-weighted average price of 71.81 pence per share under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,860,145 ordinary shares in issue, of which 4,952,237 are held in treasury, leaving 123,907,908 voting rights outstanding, a figure shareholders can use to assess disclosure obligations under FCA transparency rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Spark’s Take on GB:VLG Stock
According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.
Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.
To see Spark’s full report on GB:VLG stock, click here.
More about Venture Life
Venture Life Group is an international consumer self-care company operating in the global consumer healthcare sector. Headquartered in the UK, it focuses on proactive healthy longevity and commercialises products such as Balance Activ for women’s intimate health, Earol for ENT care, Lift and Glucogel for energy and glucose management, and the Health & Her range for the hormonal lifecycle, sold via retail and e-commerce channels worldwide.
Average Trading Volume: 276,369
Technical Sentiment Signal: Buy
Current Market Cap: £87.68M
Learn more about VLG stock on TipRanks’ Stock Analysis page.

